Environmental Chemical Contribution to the Modulation of Bile Acid Homeostasis and Farnesoid X Receptor Signaling

被引:7
|
作者
Taylor, Rulaiha E. [1 ]
Bhattacharya, Anisha [1 ]
Guo, Grace L. [1 ,2 ,3 ,4 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, Piscataway, NJ USA
[2] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA
[3] Rutgers State Univ, Rutgers Ctr Lipid Res, Piscataway, NJ USA
[4] VA New Jersey Hlth Care Syst, Vet Adm Med Ctr, E Orange, NJ USA
基金
美国国家卫生研究院;
关键词
ARYL-HYDROCARBON RECEPTOR; FATTY LIVER-DISEASE; BREAST-CANCER RISK; NONALCOHOLIC STEATOHEPATITIS; ORGANOCHLORINE PESTICIDES; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; PERFLUOROALKYL SULFONATES; ENDOGENOUS BIOMARKERS; EXPRESSION CLONING; OBETICHOLIC ACID;
D O I
10.1124/dmd.121.000388
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Maintaining bile acid (BA) homeostasis is important and regulated by BA activated receptors and signaling pathways. Farnesoid X receptor (FXR) and its regulated target networks in both the liver and the intestines are critical in suppressing BA synthesis and promoting BA transport and enterohepatic circulation. In addition, FXR is critical in regulating lipid metabolism and reducing inflammation, processes critical in the development of cholestasis and fatty liver diseases. BAs are modulated by, but also control, gut microflora. Environmental chemical exposure could affect liver disease development. However, the effects and the mechanisms by which environmental chemicals interact with FXR to affect BA homeostasis are only emerging. In this minireview, our focus is to provide evidence from reports that determine the effects of environmental or therapeutic exposure on altering homeostasis and functions of BAs and FXR. Understanding these effects will help to determine liver disease pathogenesis and provide better prevention and treatment in the future. SIGNIFICANCE STATEMENT Environmental chemical exposure significantly contributes to the development of cholestasis and nonalcoholic steatohepatitis (NASH). The impact of exposures on bile acid (BA) signaling and Farnesoid X receptor-mediated gut-liver crosstalk is emerging. However, there is still a huge gap in understanding how these chemicals contribute to the dysregulation of BA homeostasis and how this dysregulation may promote NASH development.
引用
收藏
页码:456 / 467
页数:12
相关论文
共 50 条
  • [1] The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis
    Xiang, Dong
    Yang, Jinyu
    Liu, Lu
    Yu, Hengyi
    Gong, Xuepeng
    Liu, Dong
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [2] Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver Disease
    Halilbasic, Emina
    Fuchs, Claudia
    Traussnigg, Stefan
    Trauner, Michael
    DIGESTIVE DISEASES, 2016, 34 (05) : 580 - 588
  • [3] Obeticholic acid, a selective farnesoid X receptor agonist, regulates bile acid homeostasis in sandwich-cultured human hepatocytes
    Zhang, Yuanyuan
    Jackson, Jonathan P.
    Claire, Robert L. St., III
    Freeman, Kimberly
    Brouwer, Kenneth R.
    Edwards, Jeffrey E.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2017, 5 (04):
  • [4] Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
    Abenavoli, Ludovico
    Procopio, Anna Caterina
    Fagoonee, Sharmila
    Pellicano, Rinaldo
    Carbone, Marco
    Luzza, Francesco
    Invernizzi, Pietro
    DISEASES, 2020, 8 (02)
  • [5] Discovery of farnesoid X receptor and its role in bile acid metabolism
    Chiang, John Y. L.
    Ferrell, Jessica M.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2022, 548
  • [6] Disentangling Organ-Specific Roles of Farnesoid X Receptor in Bile Acid and Glucolipid Metabolism
    Li, Tingting
    Fu, Chenyang
    Tang, Zhongzheng
    Li, Changkun
    Hua, Duanyi
    Liu, Bei
    Tao, Zheying
    Yang, Jie
    Zhang, Li
    Cheng, Tingting
    Wang, Shujie
    Ning, Guang
    Gu, Yanyun
    LIVER INTERNATIONAL, 2025, 45 (04)
  • [7] Activation of farnesoid X receptor signaling by geniposidic acid promotes osteogenesis
    Liu, Meijing
    Jin, Fujun
    Zhang, Shuai
    Li, Shuang
    Zhu, Danqi
    Cui, Yi
    Cai, Mingxiang
    Liu, Xiangning
    Zhang, Yongbiao
    Sun, Yao
    Liu, Changhui
    Wang, Xiaogang
    PHYTOMEDICINE, 2022, 103
  • [8] Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease
    Gonzalez, Frank J.
    Jiang, Changtao
    Xie, Cen
    Patterson, Andrew D.
    DIGESTIVE DISEASES, 2017, 35 (03) : 178 - 184
  • [9] Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease
    Kim, Sun-Gi
    Kim, Byung-Kwon
    Kim, Kyumin
    Fang, Sungsoon
    ENDOCRINOLOGY AND METABOLISM, 2016, 31 (04) : 500 - 504
  • [10] Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis
    Ho, Peggy P.
    Steinman, Lawrence
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (06) : 1600 - 1605